Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mayers

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|June 13, 1998
Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobialsW Liu, Q F Liu, R Perkins, et al.
Experimental Eye Research|August 1, 1996
Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administrationA A Madu, M Mayers, R Perkins, et al.
Diabetes, Obesity & Metabolism|October 1, 2010
The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic ratsF R Macdonald, J E Peel, H B Jones, et al.
Biochemical Society Transactions|December 4, 2003
AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker ratsR M Mayers, R J Butlin, E Kilgour, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicansA Louie, W Liu, D A Miller, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 12, 1998
Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady stateU K Mian, M Mayers, Y Garg, et al.
The New England Journal of Medicine|February 6, 1986
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasisG H Friedland, B R Saltzman, M F Rogers, et al.
The Journal of Endocrinology|June 18, 2011
Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 ratsVictor P Bilan, Eman M Salah, Sheldon Bastacky, et al.
Medical Care|December 1, 1993
Who enrolled in a state program for the uninsured: was there adverse selection?P Diehr, C W Madden, D P Martin, et al.
Pediatrics|December 1, 1991
A prospective study of infants of human immunodeficiency virus seropositive and seronegative women with a history of intravenous drug use or of intravenous drug-using sex partners, in the Bronx, New York CityM M Mayers, K Davenny, E E Schoenbaum, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|June 13, 1998
Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobialsW Liu, Q F Liu, R Perkins, et al.
Experimental Eye Research|August 1, 1996
Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administrationA A Madu, M Mayers, R Perkins, et al.
Diabetes, Obesity & Metabolism|October 1, 2010
The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic ratsF R Macdonald, J E Peel, H B Jones, et al.
Biochemical Society Transactions|December 4, 2003
AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker ratsR M Mayers, R J Butlin, E Kilgour, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicansA Louie, W Liu, D A Miller, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 12, 1998
Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady stateU K Mian, M Mayers, Y Garg, et al.
The New England Journal of Medicine|February 6, 1986
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasisG H Friedland, B R Saltzman, M F Rogers, et al.
The Journal of Endocrinology|June 18, 2011
Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 ratsVictor P Bilan, Eman M Salah, Sheldon Bastacky, et al.
Medical Care|December 1, 1993
Who enrolled in a state program for the uninsured: was there adverse selection?P Diehr, C W Madden, D P Martin, et al.
Pediatrics|December 1, 1991
A prospective study of infants of human immunodeficiency virus seropositive and seronegative women with a history of intravenous drug use or of intravenous drug-using sex partners, in the Bronx, New York CityM M Mayers, K Davenny, E E Schoenbaum, et al.
Pageof 9